文献速递胸部CT

用于IB-IIA期非小细胞肺癌风险分层的多特征预测模型的开发:一项多中心分析

Development of a multi-feature predictive model for risk stratification in stage IB-IIA non-small cell lung cancer: a multicenter analysis.
PubMed 文献 · Eur J Radiol · 2025-08-24

本研究回顾性纳入三个独立队列(训练集370例、内部验证集120例、外部验证集70例)的IB-IIA期非小细胞肺癌患者,整合临床病理数据与治疗前CT影像组学和深度学习特征构建CRD联合模型预测无病生存期。CRD模型在训练集、内部验证集和外部验证集的AUC分别为0.865、0.798和0.803,外部验证集中高危组HR为17.509,C-index为0.73;SHAP分析显示影像组学特征贡献最大。

要点

  • CRD联合模型预测IB-IIA期NSCLC无病生存期,外部验证AUC为0.803。
  • 外部验证中高危组HR为17.509,C-index为0.73。
  • SHAP分析显示影像组学特征对模型性能贡献最大。

核心结论

  • 多特征联合模型能有效预测IB-IIA期NSCLC的无病生存期并识别高危患者,可能有助于个体化术后治疗策略。

研究设计与样本

  • 回顾性研究,纳入三个独立队列:训练集370例、内部验证集120例、外部验证集70例。
  • 从CT图像的肿瘤区和瘤周区提取影像组学特征构建影像组学模型。
  • 采用基于ResNet50的深度学习架构构建深度学习模型。
  • 采用逻辑回归筛选显著的临床病理因素,整合临床病理、影像组学和深度学习特征构建CRD联合模型。
  • 主要终点为无病生存期,采用SHAP方法评估模型可解释性。

诊断标准与关键数值

  • CRD模型预测无病生存期的AUC:训练集0.865、内部验证集0.798、外部验证集0.803。
  • 外部验证集中高危组HR为17.509,C-index为0.73。
  • SHAP分析显示影像组学特征对CRD模型性能贡献最大。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: This study aimed to develop a comprehensive risk stratification model for stage IB-IIA non-small cell lung cancer (NSCLC) by integrating clinicopathological data with pre-treatment CT imaging.

METHODS: This retrospective study included three independent cohorts of patients with stage IB-IIA NSCLC for model development and validation (Training: n = 370; Internal validation: n = 120; External validation: n = 70). Disease-free survival (DFS) was the primary endpoint. Radiomics features were extracted from both tumoral and peritumoral regions of CT images to construct a radiomics model. A ResNet50-based deep learning architecture was adopted to develop a deep learning model using CT imaging data. Logistic regression was used to identify significant clinicopathological factors. These components were integrated into a multi-feature combined model (CRD model) that utilized clinicopathological, radiomics, and deep learning features for DFS prediction. Model interpretability was assessed using the SHapley Additive exPlanations (SHAP) method.

RESULTS: The combined CRD model demonstrated superior performance in predicting DFS, achieving areas under the curve (AUC) of 0.865, 0.798, and 0.803 in the training, internal validation, and external validation cohorts, respectively. Patients were stratified into high- and low-risk groups using the CRD model, and in the external validation cohort, the hazard ratio (HR) for high-risk patients was 17.509, with a C-index of 0.73. SHAP analysis revealed that radiomics features contributed most significantly to the performance of the CRD model.

CONCLUSIONS: The multi-feature combined model effectively predicts DFS and identifies high-risk patients with stage IB-IIA NSCLC. It could facilitate personalized postoperative treatment strategies, improving patient outcomes.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhong X, Lin H, Zhang R, et al. Development of a multi-feature predictive model for risk stratification in stage IB-IIA non-small cell lung cancer: a multicenter analysis. Eur J Radiol. 2025. PMID: 40902436. doi:10.1016/j.ejrad.2025.112379

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。